{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:17:07Z","timestamp":1790381827034,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Measles and rubella remain global health threats, despite the availability of safe and effective vaccines. Estimates of population immunity are crucial for achieving elimination goals and assessing the impact of vaccination programs, yet conducting well-designed serosurveys can be challenging, especially in resource-limited settings. In this review, we provide a comprehensive assessment of 130 measles and rubella studies published from January 2014 to January 2024. Methodologies and design aspects of serosurveys varied greatly, including sample size, assay type, and population demographics. Most studies utilized enzyme immunoassays for IgG detection. Sample sizes showed diverse sampling methods but favored convenience sampling despite its limitations. Studies spanned 59 countries, predominantly including adults, and revealed disparities in seroprevalence across demographics, regions, and notably among migrants and women. Age-related declines in antibodies were observed, particularly among infants, and correlations between vaccination status and seropositivity varied. We conclude with an outlook on measles and rubella serosurveillance, emphasizing the need for proper survey design and the advantages of standardized, multiplex serology assays.<\/jats:p>","DOI":"10.3390\/vaccines12070816","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:40:36Z","timestamp":1721734836000},"page":"816","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serosurveillance for Measles and Rubella"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0606-1384","authenticated-orcid":false,"given":"Allison M.","family":"Brady","sequence":"first","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"El-Badry","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Padron-Regalado","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Escudero Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3545-8859","authenticated-orcid":false,"given":"Daniel L.","family":"Joo","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Rota","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4711-5767","authenticated-orcid":false,"given":"Stephen N.","family":"Crooke","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(21)02004-3","article-title":"Measles","volume":"399","author":"Hubschen","year":"2022","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(21)02691-X","article-title":"Rubella","volume":"399","author":"Winter","year":"2022","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles Vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","article-title":"Rubella","volume":"385","author":"Lambert","year":"2015","journal-title":"Lancet"},{"key":"ref_5","unstructured":"WHO (2020). Rubella vaccines: WHO position paper\u2014July 2020. Wkly. Epidemiol. Rec., 95, 306\u2013324."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1093\/infdis\/jiaa793","article-title":"Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination","volume":"224","author":"Gastanaduy","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress Toward Measles Elimination\u2014Worldwide, 2000\u20132022","volume":"72","author":"Minta","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.15585\/mmwr.mm7308a2","article-title":"Progress Toward Rubella and Congenital Rubella Syndrome Elimination\u2014Worldwide, 2012\u20132022","volume":"73","author":"Ou","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2023.09.003","article-title":"Estimates of the global burden of Congenital Rubella Syndrome, 1996\u20132019","volume":"137","author":"Vynnycky","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1016\/j.vaccine.2023.11.014","article-title":"The path to eradication of rubella","volume":"41","author":"Reef","year":"2023","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Otani, N., Shima, M., Ueda, T., Nakajima, K., Takesue, Y., Yamamoto, T., and Okuno, T. (2023). Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19. Vaccines, 11.","DOI":"10.3390\/vaccines11081358"},{"key":"ref_12","unstructured":"WHO (2024, January 05). Global Measles and Rubella Strategic Plan: 2012\u20132020. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44855\/1\/9789241503396_eng.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"A35","DOI":"10.1016\/j.vaccine.2017.10.065","article-title":"Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary","volume":"36","author":"Orenstein","year":"2018","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/j.vaccine.2020.05.003","article-title":"Global vaccine action plan lessons learned I: Recommendations for the next decade","volume":"38","author":"MacDonald","year":"2020","journal-title":"Vaccine"},{"key":"ref_15","unstructured":"WHO (2024, January 05). National Immunization Coverage Scorecards Estimates for 2019. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/337665\/9789240014398-eng.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/d41586-022-02051-w","article-title":"Pandemic drives largest drop in childhood vaccinations in 30 years","volume":"608","author":"Guglielmi","year":"2022","journal-title":"Nature"},{"key":"ref_17","unstructured":"WHO (2024, January 05). Global Progress against Measles Threatened Amidst COVID-19 Pandemic. Available online: https:\/\/www.who.int\/news\/item\/10-11-2021-global-progress-against-measles-threatened-amidst-covid-19-pandemic."},{"key":"ref_18","unstructured":"WHO (2024, January 05). Measles and Rubella Strategic Framework: 2021\u20132030. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/339801\/9789240015616-eng.pdf?sequence=1."},{"key":"ref_19","unstructured":"WHO (2020). Immunization Agenda 2030 (IA2030), WHO."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S452","DOI":"10.1093\/infdis\/jiab284","article-title":"The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade","volume":"224","author":"Lindstrand","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_21","unstructured":"World Health Organization (2015). Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS). Wkly. Epidemiol. Rec., 90, 373\u2013380."},{"key":"ref_22","unstructured":"World Health Organization (2005). Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly. Epidemiol. Rec., 80, 126\u2013132."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3201\/eid2407.171928","article-title":"Integrated serologic surveillance of population immunity and disease transmission","volume":"24","author":"Arnold","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jmv.10553","article-title":"Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection","volume":"72","author":"Ibrahim","year":"2004","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.00045-15","article-title":"Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies","volume":"29","author":"Dimech","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/14760584.2020.1745071","article-title":"Immune surveillance for vaccine-preventable diseases","volume":"19","author":"Buisman","year":"2020","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1080\/21645515.2019.1621148","article-title":"The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles","volume":"15","author":"Young","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_28","first-page":"447","article-title":"Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity","volume":"96","author":"Maldonado","year":"1995","journal-title":"Pediatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.vaccine.2007.06.020","article-title":"Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns","volume":"25","author":"Leuridan","year":"2007","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/313926","article-title":"Factors determining prevalence of maternal antibody to measles virus throughout infancy: A review","volume":"31","author":"Caceres","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/tropej\/49.5.302","article-title":"The duration of maternal measles antibodies in children","volume":"49","author":"Kilic","year":"2003","journal-title":"J. Trop. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/tropej\/fmh073","article-title":"Passive immunity to measles in the breastmilk and cord blood of some nigerian subjects","volume":"51","author":"Oyedele","year":"2005","journal-title":"J. Trop. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3329\/bmrcb.v35i3.4204","article-title":"Determining infants\u2019 age for measles vaccination based on persistence of protective level of maternal measles antibody","volume":"35","author":"Shilpi","year":"2009","journal-title":"Bangladesh Med. Res. Counc. Bull."},{"key":"ref_35","first-page":"324","article-title":"Prevalence of maternal measles, rubella, mumps and varicella antibodies in the first six months of life","volume":"52","author":"Devecioglu","year":"2018","journal-title":"Mikrobiyoloji Bul."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2012.07.035","article-title":"Measles outbreak in Europe: Susceptibility of infants too young to be immunized","volume":"30","author":"Leuridan","year":"2012","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Galipeau, Y., Greig, M., Liu, G., Driedger, M., and Langlois, M.A. (2020). Humoral Responses and Serological Assays in SARS-CoV-2 Infections. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.610688"},{"key":"ref_38","unstructured":"Buddolla, V. (2019). Chapter 7\u2014Functional and Protective Role of Neutralizing Antibodies (NAbs) against Viral Infections. Recent Developments in Applied Microbiology and Biochemistry, Academic Press."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/infdis\/jiz380","article-title":"What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review","volume":"221","author":"Bolotin","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Griffin, D.E. (2016). The Immune Response in Measles: Virus Control, Clearance and Protective Immunity. Viruses, 8.","DOI":"10.3390\/v8100282"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14760584.2019.1559063","article-title":"Current perspectives in assessing humoral immunity after measles vaccination","volume":"18","author":"Haralambieva","year":"2019","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1586\/erv.12.45","article-title":"Evaluating measles vaccines: Can we assess cellular immunity?","volume":"11","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2009.0068","article-title":"Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity","volume":"22","author":"Tosh","year":"2009","journal-title":"Viral Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: An underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop. Med. Int. Health"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.15585\/mmwr.mm6945a6","article-title":"Progress Toward Regional Measles Elimination\u2014Worldwide, 2000\u20132019","volume":"69","author":"Patel","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Shanmugasundaram, D., Awasthi, S., Dwibedi, B., Geetha, S., Jain, M., Malik, S., Patel, B., Singh, H., Tripathi, S., and Viswanathan, R. (2021). Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019-20. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009608"},{"key":"ref_48","unstructured":"WHO (2024, January 05). WHO Immunological Basis for Immunization Series, Module 7: Measles Update 2020. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/331533\/9789241516655-eng.pdf?sequence=1."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/JCM.00383-16","article-title":"Assessing Immunity to Rubella Virus: A Plea for Standardization of IgG (Immuno)assays","volume":"54","author":"Bouthry","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/JCM.00231-08","article-title":"Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter","volume":"46","author":"Dimech","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/CVI.00603-12","article-title":"Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays","volume":"20","author":"Dimech","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CVI.00688-12","article-title":"Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status","volume":"20","author":"Enders","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_53","unstructured":"WHO (2024, January 05). Chapter 9: Manual for the Laboratory-Based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome. 9 June 2018. Available online: https:\/\/www.who.int\/publications\/m\/item\/chapter-9-manual-for-the-laboratory-based-surveillance-of-measles-rubella-and-congenital-rubella-syndrome."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1590\/s1678-9946202466004","article-title":"The decline of measles antibody titers in previously vaccinated adults: A cross-sectional analysis","volume":"66","author":"Castineiras","year":"2024","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2254536","DOI":"10.1080\/21645515.2023.2254536","article-title":"Do adolescents need a rubella vaccination campaign? Rubella serosurvey among healthy children in Hangzhou, China","volume":"19","author":"Wang","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lutz, C.S., Hasan, A.Z., Bolotin, S., Crowcroft, N.S., Cutts, F.T., Joh, E., Loisate, S., Moss, W.J., Osman, S., and Hayford, K. (2023). Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: A systematic review of head-to-head analyses of measles IgG EIA and PRNT. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08199-8"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1016\/j.vaccine.2008.08.074","article-title":"Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination","volume":"26","author":"Cohen","year":"2008","journal-title":"Vaccine"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcv.2006.12.017","article-title":"Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests","volume":"38","author":"Tischer","year":"2007","journal-title":"J. Clin. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/jcm.33.4.811-815.1995","article-title":"Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody","volume":"33","author":"Ratnam","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/CVI.00681-13","article-title":"High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers","volume":"21","author":"Lambert","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Reslova, N., Michna, V., Kasny, M., Mikel, P., and Kralik, P. (2017). xMAP Technology: Applications in Detection of Pathogens. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00055"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Chan, Y., Fornace, K., Wu, L., Arnold, B.F., Priest, J.W., Martin, D.L., Chang, M.A., Cook, J., Stresman, G., and Drakeley, C. (2021). Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009457"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CVI.05537-11","article-title":"Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus","volume":"19","author":"Smits","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e02716-20","DOI":"10.1128\/JCM.02716-20","article-title":"Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity","volume":"59","author":"Coughlin","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1016\/j.vaccine.2016.06.002","article-title":"A 16-year review of seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.diagmicrobio.2019.01.009","article-title":"Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women","volume":"94","author":"Viswanathan","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijid.2019.12.015","article-title":"Seroprevalence of vaccine-preventable diseases among children and adolescents in Singapore: Results from the National Paediatric Seroprevalence Survey 2018","volume":"92","author":"Ng","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3346\/jkms.2016.31.12.1957","article-title":"Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants","volume":"31","author":"Cho","year":"2016","journal-title":"J. Korean Med. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2021.04.002","article-title":"Dynamics of maternally transferred antibodies against measles, mumps, and rubella in infants in Sri Lanka","volume":"107","author":"Muthiah","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Khampanisong, P., Pauly, M., Nouanthong, P., Vickers, M.A., Virachith, S., Xaydalasouk, K., Black, A.P., Muller, C.P., and Hubschen, J.M. (2021). Waning of maternal antibodies against measles suggests a large window of susceptibility in infants in lao people\u2019s Democratic republic. Pathogens, 10.","DOI":"10.3390\/pathogens10101316"},{"key":"ref_71","first-page":"145","article-title":"Seroprevalence of measles in Northern Greece","volume":"62","author":"Gioula","year":"2017","journal-title":"Acta Microbiol. Hell."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Bassal, R., Shohat, T., Levin, T., Pando, R., Shinar, E., Amichay, D., Barak, M., Ben-Dor, A., Bar-Haim, A., and Mendelson, E. (2022). The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015. Vaccines, 10.","DOI":"10.3390\/vaccines10070996"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Carazo, S., Billard, M.N., Boutin, A., and De Serres, G. (2020). Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: Systematic review and meta-analysis. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-4870-x"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.18521\/ktd.299941","article-title":"Antibodies against vaccine preventable diseases in pregnant women measles, mumps, rubella, varicella and tetanus in Yozgat, Turkey","volume":"9","author":"Kader","year":"2017","journal-title":"Konuralp Tip. Derg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19071","DOI":"10.1073\/pnas.1905570116","article-title":"Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood","volume":"116","author":"Rasheed","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1080\/21645515.2021.1911215","article-title":"Evaluation of measles vaccination coverage in Lincang City, Yunnan Province, China","volume":"17","author":"Yang","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.vaccine.2018.01.079","article-title":"Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016","volume":"36","author":"Freidl","year":"2018","journal-title":"Vaccine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijid.2019.11.019","article-title":"Seroprevalence of measles, mumps, and rubella and genetic characterization of mumps virus in Khartoum, Sudan","volume":"91","author":"Adam","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7883\/yoken.JJID.2015.366","article-title":"Time-Series Analysis Comparing the Prevalence of Antibodies against Nine Viral Species Found in Umbilical Cord Blood in Japan","volume":"69","author":"Takemoto","year":"2016","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Vos, R.A., Mollema, L., van Binnendijk, R., Veldhuijzen, I.K., Smits, G., Janga-Jansen, A.V.A., Baboe-Kalpoe, S., Hulshof, K., van der Klis, F.R.M., and Melker, H.E. (2019). Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands. Vaccines, 7.","DOI":"10.3390\/vaccines7040137"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s007050170121","article-title":"Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines","volume":"146","author":"Okada","year":"2001","journal-title":"Arch. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"282","DOI":"10.21101\/cejph.a4010","article-title":"Seroprevalence of rubella antibodies among adult Egyptian females aged 20\u201330 years. Is there a need for rubella vaccination?","volume":"22","author":"Gadallah","year":"2014","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ajic.2015.08.021","article-title":"Immunity of nursing students to measles, mumps, rubella, and varicella in Yozgat, Turkey","volume":"44","author":"Kader","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Zanella, B., Boccalini, S., Bonito, B., Del Riccio, M., Tiscione, E., Bonanni, P., Working Group DHS, Working Group AOUMeyer, Working Group AUSLTC, and Bechini, A. (2020). Increasing Measles Seroprevalence in a Sample of Pediatric and Adolescent Population of Tuscany (Italy): A Vaccination Campaign Success. Vaccines, 8.","DOI":"10.3390\/vaccines8030512"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"396","DOI":"10.26719\/2015.21.6.396","article-title":"Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran","volume":"21","author":"Izadi","year":"2015","journal-title":"East. Mediterr. Health J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1038\/s41598-020-62151-3","article-title":"Prevalence of measles antibodies in Sao Jose do Rio Preto, Sao Paulo, Brazil: A serological survey model","volume":"10","author":"Estofolete","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jiph.2020.01.309","article-title":"Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?","volume":"13","author":"Karadeniz","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_88","first-page":"525","article-title":"Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: Analysis of vaccine efficacy and cost-effectiveness","volume":"32","author":"Odemis","year":"2019","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3947\/ic.2023.0049","article-title":"Causes of a Low Measles Seroprevalence among Young Healthcare Workers in Korea","volume":"55","author":"Chung","year":"2023","journal-title":"Infect. Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.vaccine.2019.11.021","article-title":"Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece","volume":"38","author":"Maltezou","year":"2020","journal-title":"Vaccine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3947\/ic.2019.51.1.58","article-title":"Seroprevalence of Measles in Healthcare Workers in South Korea","volume":"51","author":"Jung","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gorun, F., Malita, D., Ciohat, I., Vilibic-Cavlek, T., Feier, H., Tabain, I., Craina, M., Cretu, O., and Navolan, D. (2021). Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization. Vaccines, 9.","DOI":"10.3390\/vaccines9020104"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5114\/ceji.2019.92789","article-title":"Seroprevalence of IgG antibodies against measles in a selected Polish population\u2014Do we need to be re-vaccinated?","volume":"44","author":"Holka","year":"2019","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Wanlapakorn, N., Wasitthankasem, R., Vichaiwattana, P., Auphimai, C., Yoocharoen, P., Vongpunsawad, S., and Poovorawan, Y. (2019). Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225606"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10096-015-2339-4","article-title":"Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: Susceptibility to measles increased from 2003 to 2013","volume":"34","author":"Plans","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/vim.2021.0226","article-title":"Rubella Humoral Immunity Among the Saudi Population of Madinah in the Western Region of Saudi Arabia","volume":"35","author":"Ibrahim","year":"2022","journal-title":"Viral Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S0950268819002280","article-title":"Application of a fast and cost-effective \u2018three-in-one\u2019 MMR ELISA as a tool for surveying anti-MMR humoral immunity: The Hungarian experience","volume":"148","author":"Borocz","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/j.vaccine.2015.04.003","article-title":"An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore","volume":"33","author":"Chua","year":"2015","journal-title":"Vaccine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1016\/j.vaccine.2020.04.024","article-title":"Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016","volume":"38","author":"Nogareda","year":"2020","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Coppeta, L., Biondi, G., Lieto, P., and Pietroiusti, A. (2019). Evaluation of immunity to measles in a cohort of Medical Students in Rome, Italy. Vaccines, 7.","DOI":"10.3390\/vaccines7040214"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.vaccine.2019.10.026","article-title":"Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran","volume":"38","author":"Zahraei","year":"2020","journal-title":"Vaccine"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e1655","DOI":"10.1016\/S2214-109X(22)00379-5","article-title":"Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: A before-and-after cross-sectional household serosurvey in four districts, 2018\u20132020","volume":"10","author":"Murhekar","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Hachiya, M., Miyano, S., Mori, Y., Vynnycky, E., Keungsaneth, P., Vongphrachanh, P., Xeuatvongsa, A., Sisouk, T., Som-Oulay, V., and Khamphaphongphane, B. (2018). Evaluation of nationwide supplementary immunization in Lao People\u2019s Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194931"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4269\/ajtmh.20-1669","article-title":"Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia","volume":"104","author":"Carcelen","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijid.2023.01.044","article-title":"Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People\u2019s Democratic Republic: Impacts of the national immunization program","volume":"129","author":"Miyano","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijregi.2022.03.001","article-title":"Effectiveness of immunization activities on measles and rubella immunity among individuals in East Sepik, Papua New Guinea: A cross-sectional study","volume":"3","author":"Ichimura","year":"2022","journal-title":"IJID Reg."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.vaccine.2019.02.037","article-title":"Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey","volume":"37","author":"Hayford","year":"2019","journal-title":"Vaccine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Anichini, G., Gandolfo, C., Fabrizi, S., Miceli, G.B., Terrosi, C., Gori Savellini, G., Prathyumnan, S., Orsi, D., Battista, G., and Cusi, M.G. (2020). Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines, 8.","DOI":"10.3390\/vaccines8010066"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/infdis\/jiac039","article-title":"In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis","volume":"226","author":"Bolotin","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"Berbers","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e45594","DOI":"10.7554\/eLife.45594","article-title":"Enteropathogen antibody dynamics and force of infection among children in low-resource settings","volume":"8","author":"Arnold","year":"2019","journal-title":"eLife"},{"key":"ref_113","unstructured":"Crooke, S.N. Personal communication."},{"key":"ref_114","unstructured":"Pan American Health Organization (2020). Multiplex Bead Assay for Integrated Serological Surveillance of Communicable Diseases in the Region of the Americas. Report of the Third Regional Meeting (Cuernavaca, 4\u20135 March 2020), Pan American Health Organization."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.vaccine.2016.06.006","article-title":"A review of testing used in seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/7\/816\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:20:58Z","timestamp":1760109658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/7\/816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":115,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["vaccines12070816"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12070816","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}